Spyre Therapeutics
SYRE
#5743
Rank
โ‚น72.70 B
Marketcap
โ‚น1,206
Share price
-5.36%
Change (1 day)
-55.41%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -โ‚น5,936

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น6,161. In 2023 the company made an earnings per share (EPS) of -โ‚น4,193 a decrease over its 2022 EPS that were of -โ‚น2,113.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น5,93641.58%
2023-โ‚น4,19398.46%
2022-โ‚น2,113-1%
2021-โ‚น2,134-34.21%
2020-โ‚น3,244-37.96%
2019-โ‚น5,22815.02%
2018-โ‚น4,54518.33%
2017-โ‚น3,841-18.92%
2016-โ‚น4,737120.2%
2015-โ‚น2,151-33.55%
2014-โ‚น3,238